Now the agency faces its biggest test yet: loosening its public safety guidance as the pandemic recedes, while simultaneously trying to prevent infection rates from spiking.
Related posts:
U.S. won’t share vaccine before all Americans receive shots, officials say
‘Exceedingly deep convictions’: Inside Xavier Becerra’s quest for health care for immigrants
U.S. surpasses 500,000 Covid deaths
How the Buffalo Bills could help reopen Broadway
Blue-state Republicans slump without Trump as foil
J&J on track to meet vaccine delivery goal, White House says
U.S. searches for new AstraZeneca vaccine producer after Emergent mix-up
Feds rethink vaccination strategy as slowing demand reveals stark divide
Pfizer and BioNTech’s Covid-19 vaccine is first to win full FDA approval
FDA sounds skeptical note on Pfizer booster shot ahead of key vote
Moderna says its booster raised antibody levels against Omicron
Supreme Court to hold special session on vaccine requirements
